Protalix BioTherapeutics, Inc. — Director's Dealing 2007

Jan 5, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORTHODONTIX INC (ORTX)
CIK: 0001006281
Period of Report: 2006-12-31

Reporting Person: Yossi Maimon (VP, Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2006-12-31	Stock Options (Right to Buy)	$0.972	A	619972	Acquired	2016-09-19	Common Stock (619972)	Direct

Footnotes

F1: 25% of the options vest on September 19, 2007. The remaining 75% vest in 12 equal quarterly installments commencing on September 19, 2007.

F2: Received in connection with the merger of Protalix Ltd. (Protalix) into a wholly-owned subsidiary of Orthodontix, Inc. in exchange for employee stock options to acquire 10,150 ordinary shares of Protalix.